Potential contribution of the JRC Nanobiotechnology Laboratory to - - PowerPoint PPT Presentation

potential contribution of the
SMART_READER_LITE
LIVE PREVIEW

Potential contribution of the JRC Nanobiotechnology Laboratory to - - PowerPoint PPT Presentation

Potential contribution of the JRC Nanobiotechnology Laboratory to NFFA project Pascal Colpo The European Commissions NFFA Nanosafety Workshop science and knowledge service Lund 9-10/01/2020 Joint Research Centre The Joint Research Centre


slide-1
SLIDE 1

The European Commission’s science and knowledge service Joint Research Centre

Potential contribution of the JRC Nanobiotechnology Laboratory to NFFA project

Pascal Colpo

NFFA Nanosafety Workshop Lund 9-10/01/2020

slide-2
SLIDE 2

The Joint Research Centre – a Directorate General in the European Commission

Mariya Gabriel Innovation, Research, Culture, Education and Youth Ursula von der Leyen EC - President Charlina Vitcheva Director-General Joint Research Centre (Acting)

slide-3
SLIDE 3

JRC's Mission

As the science and knowledge service

  • f the Commission our mission is to support

EU policies with independent evidence throughout the whole policy cycle"

"

slide-4
SLIDE 4

JRC Role: facts & figures

  • 6 locations in 5 Member States: Italy, Belgium,

Germany, The Netherlands, Spain

  • Policy neutral: has no policy agenda of its own
  • 42 lаrge scale research facilities,

more than 110 online databases

  • 1500 core research staff, 3000 total staff
  • 83% of core research staff having a PhD
  • Over 1,400 scientific publications per year
slide-5
SLIDE 5

Charlina Vitcheva

slide-6
SLIDE 6

Directorate Health, Health, Consumers & Reference Materials

Acting Director: G. Van den Eede

~ 300 00 Sta taff ff Memb mbers ers

~ 50 % f female Located ted in Geel, , Belgium m & Ispra, , Italy ly

F.2 Consume nsumer Produc ucts ts Saf afet ety y F.3 Che hemi mical al Saf afet ety y and Alte ternat rnative ive Meth thods

  • ds

F.1 Hea ealth th in Socie iety F.4 Food

  • d Fr

Fraud ud Det etect ectio ion F.5 Food

  • d and Feed

ed Com

  • mplia

ianc nce F.6 Referenc rence Mate teria ials F.7 Knowl wledge ge for r Healt alth and Consume nsumers

  • C. Nicholl

Ispra Site

  • H. Emons

Geel Site /Ispra Site

  • F. Ulberth

Geel Site / Ispra Site

A.Hoeveler

Ispra Site

  • M. Whelan

Ispra Site

  • D. Florian

Geel Site

  • G. Van den Eede

Geel Site / Ispra Site

slide-7
SLIDE 7

OUR ACTIVITIES

Health Technology

medical devices in vitro diagnostics

Nanotechnology Nanomaterials

Products Safety

nanomedicine food & consumer products safety assessment quality assurance tools PAHs in plastic and rubber

Microplastics

slide-8
SLIDE 8

Nanotechnology/nanomaterial activities

Safety assessment of nanomaterials: Harmonisation of test protocols and risk assessment methodologies Analysis of nanomaterials in food and consumer products: development of methods for detection, characterisation

Quality assurance tools Method development & validation Open Access to laboratory

Micro/nanoplastic detection and identification

Support to EU regulation Support to Innovation

Training and Capacity building

slide-9
SLIDE 9

Collaborations in the field of nanomaterials

Collaborating in Standardisation ISO TC 229 CEN TC 352 Contributing to global Harmonisation via the OECD WPMN, TGP (WNT) Exploratory and pre-normative Develop/adapt methods to investigate nanomaterials (JRCs multidisciplinary competences) Open Access to Nanobiotechnology Lab Interaction with the EU regulators COM DG's ENV, GROW, EMPL, ECHA, EFSA, EMA

NanoReg2

Involving Industry and Stakeholders Partner in European Research consortia GRACIOUS, Gov4Nano

slide-10
SLIDE 10

OPEN Access to JRC Nanobiotechnology Laboratory

  • To provide Technical and scientific support to research projects from European institutions

(Academia, Research Centres, SMEs) with :

  • A wide range of facilities and cutting-edge instrumentation for interdisciplinary studies, with a

special emphasis on characterisation of nanomaterials, microplastics, nanomedicine and advanced materials and their interactions with biological systems.

  • Expertises in biology, material sciences, chemistry, physics, nanobiotechnology.
slide-11
SLIDE 11

 Bio-interfaces characterisation  Surface modification and nano- fabrication  Environmental and bio-sensors

 Nanomaterial characterisation  Detection of nanomaterials /nanoplastics in complex matrices  Characterisation of interactions of nanomaterials nanomedicines with biological systems  Biocompatibility studies  In vitro assays, uptake studies.  Advanced material characterisation for non-bio-applications (energy, transport ..)

  • TOPICS :
slide-12
SLIDE 12

Single particle counting Direct Imaging-FIB- SEM/TEM Size Separation + detector (various)

FFF Chromatographic separation

Ensemble Optical (DLS/MALS) Electrical detection PTA-Optical Detection Disc centrifuge (CLS)

Methods applicable to particle detection and sizing

CF3 AF4

Sp-ICP-MS Analytical ultracentrifuge

Development of methodologies and protocols for particle size distribution measurements applicable to nanomaterials (pure ingredient level or extracted from complex matrixes).

BET

slide-13
SLIDE 13

Investigation of mechanisms involved in NPs toxicity Surface Characterisation Bio-interactions studies.

  • Imaging and labelling techniques: adaptation of the in

vitro test battery for High Content Imaging systems for NMs testing, miniaturisation/automation of assays

  • XPS-ToF SIMS, X-Ray diffraction
  • SPR, QCM, Circular dichroism
slide-14
SLIDE 14

Present situation

  • 3 calls published up to now
  • ~ 80-100 days of access/year
  • ~ 12 projects /call on average
  • Proposals from 9 MS
  • 3-4 instruments used by project

FROM 2017 …

slide-15
SLIDE 15

Suggestions …

  • Nano-projects are often multidisciplinary requiring different steps of characterisation with

different instruments :

  • Phys-chem characterisation of pristine nanoparticles, NPs interactions and behaviour in culture

medium (agglomeration dissolution), dosimetry, cells interactions

  • Techniques of characterisation are associated with expertise i.e. optimised protocols
  • Laboratories working in the nanosafety area are very often integrated laboratories

New NFFA Nanosafety facilities could be presented as ‘platform' associated to a 'list of instruments’

slide-16
SLIDE 16

Open Access to Nanobiotechnology Laboratory

360 360° Virt irtual l tour of Nanobio iotechnolo logy Lab

https://visitors-centre.jrc.ec.europa.eu/virtual- tour/nano/en/index.html

Open Access ss to JR JRC C In Infr frastructure Nanobio iotechnolo logy Laboratory ry

https://ec.europa.eu/jrc/en/research-facility/open- access/calls/relevance/2019-1-RD-NanoBiotech

Video Open Access to Nanobiotechnology Lab

OpenLab_HD.mp4